The IMDRF is comprised of regulatory authorities from around the world and aims to accelerate international harmonization and revision of medical device regulations. This provides an important basis for reducing regulatory effort for both authorities and companies and for exploiting synergies through regulatory cooperation.
At Swissmedic's request, the IMDRF granted the Swiss Agency for Therapeutic Products the status of Official Observer at Management Committee Meetings. This new status is an important interim step towards Swissmedic's strategic objective of being admitted as a member of the Management Committee.
Read more online